These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28863330)

  • 21. Characterising the chemical and physical properties of phase-change nanodroplets.
    Zhang W; Metzger H; Vlatakis S; Claxton A; Carbajal MA; Fung LF; Mason J; Chan KLA; Pouliopoulos AN; Fleck RA; Prentice P; Thanou M
    Ultrason Sonochem; 2023 Jul; 97():106445. PubMed ID: 37257208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI of perfluorocarbon emulsion kinetics in rodent mammary tumours.
    Fan X; River JN; Muresan AS; Popescu C; Zamora M; Culp RM; Karczmar GS
    Phys Med Biol; 2006 Jan; 51(2):211-20. PubMed ID: 16394334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of ¹⁸F-labeled BODIPY dye as potential PET agents for myocardial perfusion imaging.
    Liu S; Li D; Shan H; Gabbaï FP; Li Z; Conti PS
    Nucl Med Biol; 2014 Jan; 41(1):120-6. PubMed ID: 24210284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of droplet size and perfluorocarbon boiling point on the frequency dependence of acoustic vaporization threshold.
    Aliabouzar M; Kumar KN; Sarkar K
    J Acoust Soc Am; 2019 Feb; 145(2):1105. PubMed ID: 30823782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional ultrasound-triggered phase-shift perfluorocarbon nanodroplets for cancer therapy.
    Guo R; Xu N; Liu Y; Ling G; Yu J; Zhang P
    Ultrasound Med Biol; 2021 Aug; 47(8):2064-2079. PubMed ID: 33992473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the Theranostic Potential of Perfluorohexane-Based Acoustic Nanodroplets.
    Abdalkader R; Unga J; Yamashita F; Maruyama K; Hashida M
    Biol Pharm Bull; 2019 Dec; 42(12):2038-2044. PubMed ID: 31554747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative.
    Ross TL; Honer M; Lam PY; Mindt TL; Groehn V; Schibli R; Schubiger PA; Ametamey SM
    Bioconjug Chem; 2008 Dec; 19(12):2462-70. PubMed ID: 19053298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidic preparation of various perfluorocarbon nanodroplets: Characterization and determination of acoustic droplet vaporization (ADV) threshold.
    Melich R; Bussat P; Morici L; Vivien A; Gaud E; Bettinger T; Cherkaoui S
    Int J Pharm; 2020 Sep; 587():119651. PubMed ID: 32707242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Light-activated doxorubicin-encapsulated perfluorocarbon nanodroplets for on-demand drug delivery in an in vitro angiogenesis model: Comparison between perfluoropentane and perfluorohexane.
    Yuan Z; Demith A; Stoffel R; Zhang Z; Park YC
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110484. PubMed ID: 31522023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of fluorine-18 radio-labeled serum albumins for PET blood pool imaging.
    Basuli F; Li C; Xu B; Williams M; Wong K; Coble VL; Vasalatiy O; Seidel J; Green MV; Griffiths GL; Choyke PL; Jagoda EM
    Nucl Med Biol; 2015 Mar; 42(3):219-25. PubMed ID: 25533724
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [(18)F]-Organotrifluoroborates as Radioprosthetic Groups for PET Imaging: From Design Principles to Preclinical Applications.
    Perrin DM
    Acc Chem Res; 2016 Jul; 49(7):1333-43. PubMed ID: 27054808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and preclinical evaluation of an 18F labeled PDE7 inhibitor for PET neuroimaging.
    Thomae D; Servaes S; Vazquez N; Wyffels L; Dedeurwaerdere S; Van der Veken P; Joossens J; Augustyns K; Stroobants S; Staelens S
    Nucl Med Biol; 2015 Dec; 42(12):975-81. PubMed ID: 26330158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ¹⁸F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography.
    Sarparanta M; Mäkilä E; Heikkilä T; Salonen J; Kukk E; Lehto VP; Santos HA; Hirvonen J; Airaksinen AJ
    Mol Pharm; 2011 Oct; 8(5):1799-806. PubMed ID: 21875120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous Nucleation of Stable Perfluorocarbon Emulsions for Ultrasound Contrast Agents.
    Li DS; Schneewind S; Bruce M; Khaing Z; O'Donnell M; Pozzo L
    Nano Lett; 2019 Jan; 19(1):173-181. PubMed ID: 30543289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions.
    Rapoport N; Nam KH; Gupta R; Gao Z; Mohan P; Payne A; Todd N; Liu X; Kim T; Shea J; Scaife C; Parker DL; Jeong EK; Kennedy AM
    J Control Release; 2011 Jul; 153(1):4-15. PubMed ID: 21277919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and evaluation of (S)-2-(2-[18F]fluoroethoxy)-4-([3-methyl-1-(2-piperidin-1-yl-phenyl)-butyl-carbamoyl]-methyl)-benzoic acid ([18F]repaglinide): a promising radioligand for quantification of pancreatic beta-cell mass with positron emission tomography (PET).
    Wängler B; Schneider S; Thews O; Schirrmacher E; Comagic S; Feilen P; Schwanstecher C; Schwanstecher M; Shiue CY; Alavi A; Höhnemann S; Piel M; Rösch F; Schirrmacher R
    Nucl Med Biol; 2004 Jul; 31(5):639-47. PubMed ID: 15219283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fate of linear and branched polyether-lipids in vivo in comparison to their liposomal formulations by 18F-radiolabeling and positron emission tomography.
    Reibel AT; Müller SS; Pektor S; Bausbacher N; Miederer M; Frey H; Rösch F
    Biomacromolecules; 2015 Mar; 16(3):842-51. PubMed ID: 25647509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-step radiosynthesis and in vivo evaluation of a novel fluorine-18 labeled hippurate for use as a PET renal agent.
    Pathuri G; Hedrick AF; Awasthi V; Gali H
    Nucl Med Biol; 2012 Nov; 39(8):1195-201. PubMed ID: 22898317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.
    Ganguly T; Dannoon S; Hopkins MR; Murphy S; Cahaya H; Blecha JE; Jivan S; Drake CR; Barinka C; Jones EF; VanBrocklin HF; Berkman CE
    Nucl Med Biol; 2015 Oct; 42(10):780-7. PubMed ID: 26169882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.